Analysis of serious weight gain in patients using alectinib for ALK positive lung cancer, semaglutide a potential treatment for serious weight gain from ALK tyrosine kinase inhibitors
Nov 1: Mercks blockbuster Keytruda racked up another FDA approval Wednesday, as the company announced that the anti-PD-1 therapy is now authorizedin combination with gemcitabine and cisplatinto treat patients with locally advanced unresectable or metastatic biliary tract cancer (BTC)
A.JanmeyP
Unlike natural ageing, the Ozempic Face has manifested in a much younger patient cohort, as characterised by loss of fat, elastin and collagen, muscle atrophy, and excessive skin laxity, leading to changes in facial contours and overall appearance.[iv] The aesthetic sector is responding by offering cosmetic treatments to patients as a solution to restore volume, manage excess skin, and mitigate the hollowed facial appearance with dermal fillers, energy-based skin-tightening, and surgical intervention
Don't just follow a trendunderstand what your body actually needs
Fast approval and shipping
